PRELUDE CAPITAL MANAGEMENT, LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 201 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$11,000
+10.0%
7080.0%0.00%0.0%
Q4 2018$10,000
-23.1%
7080.0%0.00%0.0%
Q3 2018$13,000
-72.9%
708
-75.2%
0.00%
-66.7%
Q2 2018$48,000
-91.7%
2,852
-90.3%
0.00%
-92.9%
Q1 2018$578,000
+1505.6%
29,482
+1537.9%
0.04%
+1300.0%
Q4 2017$36,000
+89.5%
1,800
+12.5%
0.00%
+50.0%
Q3 2016$19,000
-82.9%
1,600
-87.6%
0.00%
-87.5%
Q2 2016$111,000
+177.5%
12,900
+207.5%
0.02%
+166.7%
Q1 2016$40,000
-59.6%
4,195
-26.4%
0.01%
-60.0%
Q4 2015$99,000
+11.2%
5,700
-13.6%
0.02%
+15.4%
Q3 2015$89,000
+9.9%
6,600
+83.3%
0.01%
+18.2%
Q2 2015$81,000
-19.0%
3,600
-48.6%
0.01%
-21.4%
Q1 2015$100,000
+132.6%
7,000
+105.9%
0.01%
+133.3%
Q1 2014$43,000
-84.8%
3,400
-81.9%
0.01%
-87.2%
Q4 2013$282,000
+35.6%
18,8220.0%0.05%
+38.2%
Q3 2013$208,000
-44.7%
18,822
-60.2%
0.03%
-58.0%
Q2 2013$376,000
-45.3%
47,241
-60.4%
0.08%
-36.7%
Q1 2013$687,000119,2410.13%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Third Security, LLC 19,305,403$233,209,00010.86%
BB BIOTECH AG 7,379,832$89,148,0003.13%
SENZAR ASSET MANAGEMENT, LLC 550,544$6,650,572,0001.72%
SNYDER CAPITAL MANAGEMENT L P 2,232,114$26,964,0001.69%
Sterling Global Strategies LLC 22,000$266,0000.98%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,290,024$112,223,0000.98%
MSD Partners, L.P. 965,000$11,657,0000.94%
DOHENY ASSET MANAGEMENT /CA 130,950$1,582,0000.81%
Taylor Wealth Management Partners 128,110$1,548,0000.69%
Bellevue Group AG 318,000$3,841,0000.69%
View complete list of HALOZYME THERAPEUTICS INC shareholders